ERS International Congress, Milan 2017

Browse by day: Saturday, 09.09.2017 Sunday, 10.09.2017 Monday, 11.09.2017 Tuesday, 12.09.2017 Wednesday, 13.09.2017		Sponsored symposia: Industry Evening Symposium at ERS 2017: “Evolving Concepts in Asthma with Type 2 Inflammation: the Role of Biologics”

Citations should be made in the following way: Authors. Title. Eur Respir J 2017; 50: Suppl. 61, abstract number.

Oral Presentation
Chairs: J. Chalmers (Dundee, United Kingdom), E. Polverino (Barcelona, Spain)

Late Breaking Abstract - The prevalence and burden of Pseudomonas aeruginosa among bronchiectasis patients in Europe- data from the FRIENDS cohort J. Chalmers (Dundee, United Kingdom)
The association between gastro-oesophageal reflux and exacerbations of bronchiectasis: data from the EMBARC registry M. Mcdonnell (Galway, Ireland)
Sputum Pregnancy Zone Protein (PZP) - a potential biomarker of bronchiectasis severity A. Smith (Dundee, United Kingdom)
Reduction of the cost associated with exacerbations after treatment with nebulized sodium colistimethate (Promixin®) in patients with bronchiectasis (BQ) and chronic bronchial infection (CBI) with Pseudomonas aeruginosa (PsA). E. Garcia Cortacero (Granada, Spain)
Eradication treatment in Non CF bronchiectasis: The effect of inhaled antibiotics (tobramycin and colistin) on patients with pseudomonas aeruginosa M. Kaponi (ATHENS, Greece)
The Epidemiology of Pulmonary Nontuberculous Mycobacterial Disease in Japan H. Namkoong (Tokyo, Japan)
Changing epidemiology of pulmonary nontuberculous mycobacteria infections over a 20-year period in Biscay, Spain S. Pedrero Tejada (Santurtzi (Vizcaya), Spain)
Cardiovascular disease risk in patients with nontuberculous mycobacteria disease treated with macrolide J. Kang (Seoul, Republic of Korea)